AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

MSN Sita-M 50/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview MSN Sita-M 50/1000 Tablet ER

Sita-M 50/1000 ER tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Sita-M 50/1000 ER may be used independently or in conjunction with other anti-diabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and other medications. Consuming the tablet with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for effective diabetes control. Common adverse effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia, particularly if used with insulin or sulfonylureas, is a potential side effect requiring appropriate management. This medication is not universally suitable. Prior medical history of cardiac, hepatic, or renal dysfunction, pancreatic issues, or excessive alcohol consumption should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals must seek medical counsel. Interactions with other medications are possible; therefore, comprehensive disclosure of all concurrent medications is necessary. Alcohol consumption should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels is integral to the treatment plan.

Primary Ingredients of MSN Sita-M 50/1000 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of MSN Sita-M 50/1000 Tablet ER

Managing Type 2 Diabetes

Major Benefits of MSN Sita-M 50/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or divide it. Consume Sita-M 50/1000 ER tablets with food.

Common Side effects of MSN Sita-M 50/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use MSN Sita-M 50/1000 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The extended-release Sita-M 50/1000 tablet should be taken with a meal.

How MSN Sita-M 50/1000 Tablet ER works:

Sita-M 50/1000 ER tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and MSN Sita-M 50/1000 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Sita-M 50/1000 tablet may pose pregnancy risks. While human research is scant, animal studies indicate potential harm to a fetus. Prescribing will involve a physician's assessment of benefits versus potential risks. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Sita-M 50/1000 tablets (MSN) are likely not safe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using MSN Sita-M 50/1000 ER tablets, as dose modification may be necessary. Consult your physician for guidance. The use of MSN Sita-M 50/1000 ER tablets is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Sita-M 50/1000 tablets (MSN) are likely contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take MSN Sita-M 50/1000 Tablet ER :

Should you forget to take a scheduled MSN Sita-M 50/1000 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About MSN Sita-M 50/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on MSN Sita-M 50/1000 Tablet ER

MSN Sita-M 50/1000 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of MSN Sita-M 50/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
MSN Sita-M 50/1000 Tablet ER may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
MSN Sita-M 50/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and MSN Sita-M 50/1000 Tablet ER is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin, a component of MSN Sita-M 50/1000 Tablet ER, can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
MSN Sita-M 50/1000 ER tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita-M 50/1000 Tablet ER may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Avoid MSN Sita-M 50/1000 Tablet ER if you are allergic to any ingredient. This medication is also contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and MSN Sita-M 50/1000 Tablet ER is unsafe due to the increased risk of lactic acidosis.
Metformin, a component of MSN Sita-M 50/1000 Tablet ER, can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 50/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
MSN Sita-M 50/1000 ER tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita-M 50/1000 Tablet ER may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita-M 50/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita-M 50/1000 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Metformin, a component of MSN Sita-M 50/1000 Tablet ER, can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 50/1000 Tablet ER can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
MSN Sita-M 50/1000 Tablet...
118